Aralez Pharmaceuticals Inc.
ARLZ
ARLZ was delisted on the 20th of August, 2018.
4 hedge funds and large institutions have $1K invested in Aralez Pharmaceuticals Inc. in 2018 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 46 closing their positions.
92% less funds holding
Funds holding: 48 → 4 (-44)
96% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 46
100% less capital invested
Capital invested by funds: $1.8M → $1K (-$1.8M)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AA
Ancora Advisors
Cleveland,
Ohio
|
+$2.14K |
| 2 |
Simplex Trading
Chicago,
Illinois
|
+$102 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$576K |
| 2 |
Wells Fargo
San Francisco,
California
|
-$282K |
| 3 |
SM
Salzhauer Michael
|
-$174K |
| 4 |
PCM
PAR Capital Management
Boston,
Massachusetts
|
-$168K |
| 5 |
Renaissance Technologies
New York
|
-$109K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SC
26
Scotia Capital
Toronto,
Ontario, Canada
| – | -$23K | -15,268 | Closed |
|
|
FAAS
27
First Allied Advisory Services
San Diego,
California
| – | -$5K | -15,000 | Closed |
|
28
Wolverine Trading
Chicago,
Illinois
| – | -$18K | -11,921 | Closed |
|
29
UBS Group
Zurich,
Switzerland
| – | -$3K | -8,640 | Closed |
|
|
LTFS
30
Ladenburg Thalmann Financial Services
Miami,
Florida
| – | -$9K | -6,004 | Closed |
|
|
FDCDDQ
31
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| – | -$1.8K | -5,247 | Closed |
|
32
Bank of America
Charlotte,
North Carolina
| – | -$2K | -4,923 | Closed |
|
|
AG
33
Advisor Group
Phoenix,
Arizona
| – | -$1K | -3,820 | Closed |
|
34
CIBC Private Wealth Group
Atlanta,
Georgia
| – | -$1K | -3,362 | Closed |
|
35
Bank of Montreal
Toronto,
Ontario, Canada
| – | -$1K | -2,551 | Closed |
|
|
36
Simplex Trading
Chicago,
Illinois
| – | +$102 | +400 | New |
|
|
AA
37
Ancora Advisors
Cleveland,
Ohio
| – | +$2.14K | +8,376 | New |
|
ARLZ Hedge Fund Activity: Q3 2018 in Review
4 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in Aralez Pharmaceuticals Inc. (ARLZ) for Q3 2018, worth a combined $1K — down 100% from $1.8M a quarter earlier.
Sellers outnumbered buyers: 46 funds closed out of ARLZ and 2 opened new positions — a net loss of 44 holders — while 1 trimmed existing stakes and 0 added.
The largest buyer was Ancora Advisors, opening a new position worth an estimated $2.14K. The largest seller was Deerfield Management, exiting entirely with an estimated $576K sold.
- 4 institutional investors held Aralez Pharmaceuticals Inc. (ARLZ) as of Q3 2018, down from 48 in Q2 2018.
- Funds reported $1K of Aralez Pharmaceuticals Inc. stock for Q3 2018, down 100% quarter-over-quarter.
- 2 funds opened new Aralez Pharmaceuticals Inc. positions in Q3 2018 and 46 closed out, a net change of -44 holders.
- The largest Aralez Pharmaceuticals Inc. buyer in Q3 2018 was Ancora Advisors, an estimated $2.14K added.
- The largest Aralez Pharmaceuticals Inc. seller in Q3 2018 was Deerfield Management, an estimated $576K sold.
Based on aggregated 13F filings for Q3 2018.